Caspase-9 is required for normal hematopoietic development and protection from alkylator-induced DNA damage in mice
Elise Peterson Lu, Michael McLellan, Li Ding, Robert Fulton, Elaine R Mardis, Richard K Wilson, Christopher A Miller, Peter Westervelt, John F DiPersio, Daniel C Link, Matthew J Walter, Timothy J Ley, Timothy A Graubert
2014-12-18
Abstract:Apoptosis and the DNA damage responses have been implicated in hematopoietic development and differentiation, as well as in the pathogenesis of myelodysplastic syndromes (MDS) and leukemia. However, the importance of late-stage mediators of apoptosis in hematopoiesis and leukemogenesis has not been elucidated. Here, we examine the role of caspase-9 (Casp9), the initiator caspase of the intrinsic apoptotic cascade, in murine fetal and adult hematopoiesis. Casp9 deficiency resulted in decreased erythroid and B-cell progenitor abundance and impaired function of hematopoietic stem cells after transplantation. Mouse bone marrow chimeras lacking Casp9 or its cofactor Apaf1 developed low white blood cell counts, decreased B-cell numbers, anemia, and reduced survival. Defects in apoptosis have also been previously implicated in susceptibility to therapy-related leukemia, a disease caused by …
What problem does this paper attempt to address?